Strain Data Sheet
ANIMAL SEARCH SYSTEM
Data update: Aug 20, 2019
Health Report   PCR Protocol   Thawing Method
embryos / sperm >
  Mouse Marking
Figure
  Order
RBRC No. RBRC05722  
Type Targeted MutationCartagena  
Species Mus musculus  
Strain name C57BL/6-Wbp2nl<tm1a(EUCOMM)Osb>  
Former Common name PAWP floxed  
H-2 Haplotype No Data  
ES cell line EGR-G101 [C57BL/6-Tg(CAG/Acr-EGFP)C3-N01-FJ002Osb]  
Background strain No Data  
Appearance
 1 Appearance No Data  
Genotype No Data  
Strain development Developed by Yuhkoh Satouh and Masaru Okabe, Research Institute for Microbial Diseases, Osaka University in 2011.  
Strain description Wbp2nl floxed mice. Exons 2 to 4 were flanked by loxP sites.  
Colony maintenance Homozygote x Homozygote [C57BL/6NJcl]  
Health Report No Data  
Gene Details
Promoter No Data  
 1 Symbol IRES  
Symbol name internal ribosomal entry site (EMCV)  
Chromosome 15  
Common name internal ribosomal entry site from EMCV  
Symbol description No Data  
 2 Symbol neo  
Symbol name neomycin resistance gene (E. coli)  
Chromosome 15  
Common name neo; neomycin;  
Symbol description No Data  
 3 Symbol En2  
Symbol name En2 SA (mouse En2 intron 2/exon 3 splice acceptor sequence)  
Chromosome 15  
Common name No Data  
Symbol description No Data  
 4 Symbol Frt  
Symbol name yeast FRT (flippase recombination target) site  
Chromosome 15  
Common name No Data  
Symbol description No Data  
 5 Symbol Wbp2nl  
Symbol name WBP2 N-terminal like  
Chromosome 15  
Common name No Data  
Symbol description No Data  
 6 Symbol lacZ  
Symbol name beta-galactosidase (E. coli)  
Chromosome 15  
Common name No Data  
Symbol description No Data  
 7 Symbol loxP  
Symbol name phage P1 loxP  
Chromosome 15  
Common name No Data  
Symbol description No Data  
References Unpublished  
Research applications Cre/loxP system,
Developmental Biology Research,
FLP/frt system,
Fluorescent Proteins/lacZ System  
Specific Term and Conditions The following terms and conditions will be requested by the DEPOSITOR.
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Biol Reprod. 2015 Oct;93(4):94. doi: 10.1095/biolreprod.115.131441. Epub 2015 Sep 16.
Using the BIOLOGICAL RESOURCE is limited to the academic research of academic institutions. These strains were established by the DEPOSITOR by using knockout vectors of EUCOMM Consortium. The RECIPIENT shall acknowledge the EUCOMM Consortium as the source of the vectors of the strains. The RECIPIENT must contact in advance the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.  
Additional information
 1 Lab HP  
Depositor Okabe, Masaru (Osaka university)  Okabe, Masaru 
Strain Status /
Availability
(Expected delivery)

back Back
RIKEN BioResource Research Center

English page click here ANIMAL SEARCH SYSTEM